JPH01279864A - 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体 - Google Patents

新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体

Info

Publication number
JPH01279864A
JPH01279864A JP1071587A JP7158789A JPH01279864A JP H01279864 A JPH01279864 A JP H01279864A JP 1071587 A JP1071587 A JP 1071587A JP 7158789 A JP7158789 A JP 7158789A JP H01279864 A JPH01279864 A JP H01279864A
Authority
JP
Japan
Prior art keywords
carbon atoms
amino
group
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1071587A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0428263B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Jr Carroll G Temple
キャロル ジー テンプル ジュニア
John A Montgomery
ジョン エイ モントゴメリー
Robert D Elliott
ロバート ディ エリオット
Glynn P Wheeler
グリン ピー ウィーラー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Research Institute
Original Assignee
Southern Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/354,164 external-priority patent/US4450160A/en
Application filed by Southern Research Institute filed Critical Southern Research Institute
Publication of JPH01279864A publication Critical patent/JPH01279864A/ja
Publication of JPH0428263B2 publication Critical patent/JPH0428263B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
JP1071587A 1981-03-24 1989-03-23 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体 Granted JPH01279864A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24715881A 1981-03-24 1981-03-24
US354164 1982-03-03
US06/354,164 US4450160A (en) 1981-12-07 1982-03-03 1,2-Dihydropyrido[3,4-b]-pyrazines and method and intermediates for preparing same
US247158 2002-09-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP57048068A Division JPS57188588A (en) 1981-03-24 1982-03-24 Novel 1,2-dihydropyrido(3,4-b)-pyrazines, manufacture and intermediates

Publications (2)

Publication Number Publication Date
JPH01279864A true JPH01279864A (ja) 1989-11-10
JPH0428263B2 JPH0428263B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-05-13

Family

ID=26938495

Family Applications (3)

Application Number Title Priority Date Filing Date
JP1071587A Granted JPH01279864A (ja) 1981-03-24 1989-03-23 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体
JP1071588A Granted JPH01279865A (ja) 1981-03-24 1989-03-23 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体
JP1071586A Granted JPH01279863A (ja) 1981-03-24 1989-03-23 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP1071588A Granted JPH01279865A (ja) 1981-03-24 1989-03-23 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体
JP1071586A Granted JPH01279863A (ja) 1981-03-24 1989-03-23 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体

Country Status (9)

Country Link
EP (2) EP0061178B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (3) JPH01279864A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU547435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1198111A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3269284D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK164160C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES515559A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI75567C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO156942C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600716A (en) * 1982-03-26 1986-07-15 Southern Research Institute 1,2-dihydropyrido[3,4-b]pyrazines
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US6388076B1 (en) * 1995-06-19 2002-05-14 Ontogen Corporation Protein tyrosine phosphatase-inhibiting compounds
JP4380847B2 (ja) 1999-07-21 2009-12-09 東京自動機工株式会社 伝動機の伝達体加圧制御装置

Also Published As

Publication number Publication date
NO820953L (no) 1982-09-27
NO156942B (no) 1987-09-14
DK164160B (da) 1992-05-18
DK133782A (da) 1982-09-25
JPH0428697B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-05-15
AU547435B2 (en) 1985-10-17
FI820982L (fi) 1982-09-25
DK164160C (da) 1992-11-02
EP0061178A3 (en) 1982-12-01
AU8182282A (en) 1982-09-30
EP0061178B1 (en) 1986-02-26
JPH0427234B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-05-11
ES515558A0 (es) 1983-10-16
JPH01279863A (ja) 1989-11-10
JPH01279865A (ja) 1989-11-10
EP0061178A2 (en) 1982-09-29
EP0151765A3 (en) 1985-09-18
DE3269284D1 (en) 1986-04-03
ES8400435A1 (es) 1983-10-16
NO156942C (no) 1987-12-23
JPH0428263B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-05-13
EP0151765B1 (en) 1987-07-08
EP0151765A2 (en) 1985-08-21
CA1198111A (en) 1985-12-17
FI75567B (fi) 1988-03-31
ES8400434A1 (es) 1983-10-16
ES515559A0 (es) 1983-10-16
FI75567C (fi) 1988-07-11

Similar Documents

Publication Publication Date Title
US7378424B2 (en) Derivatives of pyrimido[6, 1-A]isoquinolin-4-one
SI9300287A (en) Process for preparing aryl piperazinyl-heterocyclic compounds
JPH11501925A (ja) 置換N−アリールメチルおよびヘテロシクリルメチル−1H−ピラゾロ〔3,4−b〕キノリン−4−アミン並びにそれらを含有する組成物
US4492695A (en) Therapeutically useful imidazo[1,2-a]pyridine derivatives
US5721267A (en) Chemotherapeutic pyrrolocarbazole derivatives
FI66868C (fi) Foerfarande foer framstaellning av imidazo(1,2-a)kinoxalinmetanoler anvaendbara saosom laekemedel
JPH0124786B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4450160A (en) 1,2-Dihydropyrido[3,4-b]-pyrazines and method and intermediates for preparing same
JPH01279864A (ja) 新規の1,2―ジヒドロピリド〔3,4―b〕―ピラジン類製造用の中間体
EP0063084B1 (fr) Dérivés de phénéthanolamine, leur préparation et leur application en thérapeutique
US4511721A (en) Intermediate for preparing antifungal 1,2-dihydropyrido[3,4-b]-pyrazines
US6265402B1 (en) Use of 2-phenylmorpholin-5-one derivatives
US4104385A (en) Cyclic alkylidenyl N-[6-(amino)-3-pyridazinyl]aminomethylenemalonates
EP0090681B1 (en) Novel 1,2-dihydropyrido-(3,4-b)pyrazines
US4600716A (en) 1,2-dihydropyrido[3,4-b]pyrazines
JPH0355473B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4187373A (en) Novel dihydrobenzanthracene derivatives
US4645840A (en) Intermediates for preparing 1,2-dihydropyrido[3,4-b]-pyrazines
US5095017A (en) 1,2-dihydropyrido(3,4,-b)pyrazines as fungicides
FR2475550A1 (fr) 4-(2-(1h-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)-methoxypyrazolo(3,4-b) pyridines a action anti-bacterienne, et leur procede de preparation
US3459750A (en) Asymmetrical triazines
JPS6346064B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA1216587A (en) 1,2-dihydropyrido [3,4-b]-pyrazines and method and intermediates for preparing same
CA1116605A (en) Bis(2-imidazolin-2-ylhydrazone)-9,10-dihydro-9,10- anthracenedicarboxaldehydes
FR2593181A1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique